Structure Therapeutics Inc. — Director's Dealing 2023

Feb 3, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Structure Therapeutics Inc. (GPCR)
CIK: 0001888886
Period of Report: 2023-02-02

Reporting Person: Ma Yingli (Chief Technology Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock option (right to buy)	$2.60	2032-01-19	Ordinary Shares (400000)		Direct

Footnotes

F1: 1/4th of the shares vested one year after May 10, 2021 (the "Vesting Commencement Date"); the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.